Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HexaPro - Vaxxas

Next Previous
Drug Profile

HexaPro - Vaxxas

Alternative Names: HexaPro HD-MAP vaccine; HexaPro SARS-COV2 Vaccine; SARS-CoV-2 Spike Vaccine

Latest Information Update: 08 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Texas at Austin
  • Developer Griffith University; University of Queensland
  • Class COVID-19 vaccines; Subunit vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I COVID 2019 infections

Most Recent Events

  • 28 Mar 2025 Vaxxas has patent protection for high-density microarray patch (HD-MAP) vaccination technology in Europe, Asia and Australia
  • 28 Mar 2025 Vaxxas completes a phase I trial in COVID-19 infections (Prevention) in Australia (Transdermal) before March 2025
  • 04 Mar 2025 Pharmacodynamics data from a preclinical studies in COVID-19 infections released by Vaxxas

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top